Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Zinc recalled?

Yes — there is an active recall. 47 ongoing FDA recalls mention Zinc (156 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Zinc. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Zinc recalls on record

none so far in 2026; 156 on record, newest first
Class II · Moderate risk

Zinc Sulfate

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3226-07 D-0294-2016
Class II · Moderate risk

Trace Elements-4

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3201-07 D-0283-2016
Class II · Moderate risk

Zinc 5 mg/ml Injectable

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination The Compounding Pharmacy of America D-1662-2015
Class II · Moderate risk

Tpn 3:1

Lack of Assurance of Sterility: Sterility of product is not assured.

Terminated Sterility / contamination Lincare, Inc. D-1163-2015
Class II · Moderate risk

Tpn 3:1

Lack of Assurance of Sterility: Sterility of product is not assured.

Terminated Sterility / contamination Lincare, Inc. D-1159-2015
Class II · Moderate risk

Tpn 2:1

Lack of Assurance of Sterility: Sterility of product is not assured.

Terminated Sterility / contamination Lincare, Inc. D-1158-2015
Class II · Moderate risk

Tpn 3:1

Lack of Assurance of Sterility: Sterility of product is not assured.

Terminated Sterility / contamination Lincare, Inc. D-1156-2015
Class II · Moderate risk

Tpn 3:1

Lack of Assurance of Sterility: Sterility of product is not assured.

Terminated Sterility / contamination Lincare, Inc. D-1155-2015
Class II · Moderate risk

Tpn 3:1

Lack of Assurance of Sterility: Sterility of product is not assured.

Terminated Sterility / contamination Lincare, Inc. D-1154-2015
Class III · Low risk

Eye Drops A.C.

CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.

Terminated cGMP deviation K C Pharmaceuticals Inc D-0321-2015
Class II · Moderate risk

Zinc Pyrithione active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-957-2015
Class III · Low risk

Z-Cote Hp 1 Transparent Zinc Oxide

cGMP Deviation; The incorrect amount of a raw material was added during the manufacture of two lots of Z-COTE HP 1.

Terminated cGMP deviation Nanophase Technologies Corporation D-0238-2015
Class II · Moderate risk

Dermatend Ultra

Labeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not been shown to be safe and effective for the uses suggested in the labeling.

Terminated Labeling / mix-up Solace International Inc D-1586-2014
Class II · Moderate risk

Dermatend Original

Labeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not been shown to be safe and effective for the uses suggested in the labeling.

Terminated Labeling / mix-up Solace International Inc D-1585-2014
Class II · Moderate risk

Multitrace-4 pediatric injection

Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.

Terminated Sterility / contamination Specialty Medicine Compounding Pharmacy D-432-2014
Class II · Moderate risk

Zinc Sulfate 1 mg/ml INJECTABLE

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Terminated Sterility / contamination Beacon Hill Medical Pharmacy, P.C. D-1011-2013
Class II · Moderate risk

ZINC SULFATE Capsule

Labeling:Label Mixup; ZINC SULFATE Capsule, 220 mg may be potentially mislabeled as CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD52778_10, EXP: 5/20/2014; CALCITRIOL, Capsule, 0.25 mcg, NDC 00054000725, Pedigree: W003638, EXP: 6/25/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-651-2014
Class II · Moderate risk

Zinc Sulfate

Labeling: Label Mixup; ZINC SULFATE, Capsule, 50 mg may be potentially mislabeled as SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree: AD30993_14, EXP: 5/9/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-480-2014
Class II · Moderate risk

Zinc Sulfate

Labeling: Label Mixup; ZINC SULFATE, Capsule, 220 mg (50 mg Elem Zn) may be potentially mislabeled as PHOSPHORUS, Tablet, 250 mg, NDC 64980010401, Pedigree: AD56916_1, EXP: 5/21/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-479-2014
Class II · Moderate risk

Zinc Gluconate

Labeling: Label Mixup; ZINC GLUCONATE, Tablet, 50 mg may be potentially mis-labeled as ASCORBIC ACID, Chew Tablet, 500 mg, NDC 00904052660, Pedigree: AD60240_54, EXP: 5/22/2014 and ASCORBIC ACID, Chew Tablet, 250 mg, NDC 00904052260, Pedigree: W003027, EXP: 6/12/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-463-2014